John Lövrot

2.3k total citations · 2 hit papers
21 papers, 1.6k citations indexed

About

John Lövrot is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, John Lövrot has authored 21 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in John Lövrot's work include Cancer Cells and Metastasis (12 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer Immunotherapy and Biomarkers (5 papers). John Lövrot is often cited by papers focused on Cancer Cells and Metastasis (12 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer Immunotherapy and Biomarkers (5 papers). John Lövrot collaborates with scholars based in Sweden, United States and Finland. John Lövrot's co-authors include Jonas Bergh, Theodoros Foukakis, Christer Larsson, Michael Bartoschek, Kristian Pietras, Matteo Bocci, Göran Karlsson, Gyula Pekár, Nikolay Oskolkov and Åsa K. Björklund and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

John Lövrot

19 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing

2018 561 citations Michael Bartoschek, Nikolay Oskolkov et al. Nature Communications profile →
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression

2017 408 citations Asís Palazón, Petros A. Tyrakis et al. Cancer Cell profile →

Peers

Countries citing papers authored by John Lövrot

Since Specialization

Citations

This map shows the geographic impact of John Lövrot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Lövrot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Lövrot more than expected).

Fields of papers citing papers by John Lövrot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Lövrot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Lövrot. The network helps show where John Lövrot may publish in the future.

Co-authorship network of co-authors of John Lövrot

This figure shows the co-authorship network connecting the top 25 collaborators of John Lövrot. A scholar is included among the top collaborators of John Lövrot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Lövrot. John Lövrot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic and predictive implications of sterile alpha motif and HD domain‐containing protein 1 (SAMHD1) expression in breast cancer 2024 ·International Journal of Cancer ·Maria A. Kouvaraki, Ioannis Zerdes, Emmanouil G. Sifakis, (unknown), Alexios Matikas, (unknown), Una Kjällquist, Κωνσταντίνα Σταθοπούλου, John Lövrot, Amjad Alkodsi, Johan Hartman, Christos Sotiriou, François Richard, Thomas Hatschek, Nikolas Herold, Jonas Bergh, George Z. Rassidakis, Theodoros Foukakis	0
2	1668P Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction 2022 ·Annals of Oncology ·Xinsong Chen, Emmanouil G. Sifakis, Stephanie Robertson, Shiyong Neo, (unknown), Le Tong, John Lövrot, (unknown), (unknown), Sara Margolin, Jonas Bergh, Theodoros Foukakis, (unknown), Andreas Lundqvist, Ran Ma, Johan Hartman	1
3	Breast cancer patient-derived whole-tumor cell culture model for efficient drug profiling and treatment response prediction 2022 ·Proceedings of the National Academy of Sciences ·Xinsong Chen, Emmanouil G. Sifakis, Stephanie Robertson, Shiyong Neo, (unknown), Le Tong, (unknown), John Lövrot, (unknown), Sara Margolin, Jonas Bergh, Theodoros Foukakis, Jens Lagergren, Andreas Lundqvist, Ran Ma, Johan Hartman	13
4	PD-1 protein and gene expression as prognostic factors in early breast cancer 2020 ·ESMO Open ·Alexios Matikas, Ioannis Zerdes, John Lövrot, Emmanouil G. Sifakis, François Richard, Christos Sotiriou, Georgios Z. Rassidakis, Jonas Bergh, Antonis Valachis, Theodoros Foukakis	14
5	Prognostic Implications of PD-L1 Expression in Breast Cancer: Systematic Review and Meta-analysis of Immunohistochemistry and Pooled Analysis of Transcriptomic Data 2019 ·Clinical Cancer Research ·Alexios Matikas, Ioannis Zerdes, John Lövrot, François Richard, Christos Sotiriou, Jonas Bergh, Antonios Valachis, Theodoros Foukakis	73
6	A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer 2019 ·Clinical Cancer Research ·Elin Sjöberg, Max Meyrath, Laura Milde, Mercedes Herrera, John Lövrot, Daniel Hägerstrand, Oliver Frings, Margarita Bartish, Charlotte Rolny, Erik L. L. Sonnhammer, Andy Chevigné, Martin Augsten, Arne Östman	87
7	Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing breakdown → 2018 ·Nature Communications ·Michael Bartoschek, Nikolay Oskolkov, Matteo Bocci, John Lövrot, Christer Larsson, Mikael N.E. Sommarin, Chris D. Madsen, David Lindgren, Gyula Pekár, Göran Karlsson, Markus Ringnér, Jonas Bergh, Åsa K. Björklund, Kristian Pietras	561
8	Immune gene expression and response to chemotherapy in advanced breast cancer 2018 ·British Journal of Cancer ·(unknown), Theodoros Foukakis, John Lövrot, Alexios Matikas, Ioannis Zerdes, Julie Lorent, Nicholas P. Tobin, Takayuki Suzuki, Søren Brage, Lena Carlsson, Zakaria Einbeigi, Barbro Linderholm, Niklas Loman, Martin Malmberg, Mårten Fernö, Lambert Skoog, Jonas Bergh, Thomas Hatschek	37
9	A minority-group of renal cell cancer patients with high infiltration of CD20+B-cells is associated with poor prognosis 2018 ·British Journal of Cancer ·Elin Sjöberg, (unknown), John Lövrot, Artur Mezheyeuski, Martin Johansson, Ulrika Harmenberg, Lars Egevad, Per Sandström, Arne Östman	44
10	Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes 2018 ·Journal of Clinical Investigation ·(unknown), (unknown), Amjad Alkodsi, Una Kjällquist, Gustav Stålhammar, John Lövrot, (unknown), Jens Lagergren, Sampsa Hautaniemi, Johan Hartman, Jonas Bergh	108
11	Effect of CYP2C19 and CYP2D6 Genotype on Tamoxifen Treatment Outcome Indicates Endogenous and Exogenous Interplay 2018 ·Pharmacogenomics ·Sarah C. Sim, John Lövrot, Jonatan D. Lindh, Jonas Bergh, (unknown)	10
12	An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression breakdown → 2017 ·Cancer Cell ·Asís Palazón, Petros A. Tyrakis, David Macías, Pedro Veliça, Helene Rundqvist, Susan F. Fitzpatrick, (unknown), Anthony T. Phan, Niklas Loman, Ingrid Hedenfalk, Thomas Hatschek, John Lövrot, Theodoros Foukakis, Ananda W. Goldrath, Jonas Bergh, Randall S. Johnson	408
13	Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells 2017 ·JNCI Journal of the National Cancer Institute ·Ran Ma, (unknown), John Lövrot, Felix Haglund, Gustaf Rosin, (unknown), Xiaonan Zhang, (unknown), Jan Frisell, Cecilia Williams, Stig Linder, Irma Fredriksson, Johan Hartman	66
14	Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling 2017 ·BMC Cancer ·(unknown), Mattias Rantalainen, Gustav Stålhammar, John Lövrot, (unknown), Amjad Alkodsi, Ran Ma, (unknown), Johan Lindberg, Jan Frisell, Jonas Bergh, Johan Hartman	12
15	Regulation of PD-L1 in breast cancer. 2017 ·Journal of Clinical Oncology ·Ioannis Zerdes, Nikolaos Tsesmetzis, John Lövrot, Charlotte Rolny, Jonas Bergh, Georgios Z. Rassidakis, Theodoros Foukakis	0
16	Abstract P6-01-04: Evolutionary analyses of matched primary and metastatic breast cancer reveal both linear and parallel progression with lack of axillary lymph node involvement 2017 ·Cancer Research ·(unknown), (unknown), Amjad Alkodsi, Una Kjällquist, Gustav Stålhammar, John Lövrot, (unknown), Jesper Lagergren, Sampsa Hautaniemi, John Hartman, Jonas Bergh	1
17	Endothelial ALK1 Is a Therapeutic Target to Block Metastatic Dissemination of Breast Cancer 2015 ·Cancer Research ·Sara I. Cunha, Matteo Bocci, John Lövrot, (unknown), Pernilla Roswall, Eugenia Cordero, Linda S. Lindström, Michael Bartoschek, Kristian Hallermalm, R. Scott Pearsall, Aaron W. Mulivor, Ravindra Kumar, Christer Larsson, Jonas Bergh, Kristian Pietras	48
18	mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells 2015 ·Cancer Letters ·(unknown), Ran Ma, John Lövrot, Lóránd Kis, Claes Lindh, (unknown), Irma Fredriksson, Jonas Bergh, Johan Hartman	46
19	Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancer 2015 ·Molecular Oncology ·Theodoros Foukakis, John Lövrot, (unknown), (unknown), Linda S. Lindström, C. Giorgetti, Hans Jacobsson, Elham Hedayati, Jonas Bergh	11
20	Thyroid hormone inactivation in gastrointestinal stromal tumors. 2014 ·New England Journal of Medicine ·Theodoros Foukakis, John Lövrot, Jonas Bergh	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact